FutureWiseResearch: Global Market Research Reports, USA, UK

Overview

Active Implantable Devices Market Overview:

According to FutureWise analysis the market for active implantable devices is expected to register a CAGR of 6.70% from 2023-2031.

An active implantable device is medical device which intends to be totally or partially introduced, medically or surgically, into the human body. Common examples of implantable medical devices include pacemakers, breast implants, cochlear implants, intraocular lenses, artificial joints, other cardiac implants, and intrauterine contraceptive devices. They are placed into the human body either permanently or temporarily to support functions performed by specific organs or tissues, deliver medicines or monitor physiological activities. Some implants are prosthetics that mimics the original body parts and intend to replace them. These devices could be designed using exogenous materials or human tissues, such as plastics, ceramics, and metals.

With increased prevalence of chronic, age-related health conditions, fast growth in medical device is observed globally. Cloud computing, artificial intelligence and the Internet of Things (IoT) are some of the new technologies which have contributed significantly to the advancement in medical device industry. The designing of an implantable device is initiated with information gathering from three significant participants: the patient, the medical staff and the engineer. The medical doctor is a user, a researcher and a reviewer of a medical device. The main factor is that a physicians need to know how to implant, where, when, and why to implant. The increase necessity for effective safer and faster device is a significant driving factor contributing to the growth of this market.

FutureWise Market Research has published a report that provides an insightful analysis of Active Implantable Device Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Active Implantable Device Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

Major players included in the Active Implantable Devices Market:

Medtronic plc
Abbott Laboratories
Boston Scientific Corporation
BIOTRONIK SECo. KG
LivaNova PLC
Cochlear Limited
MED-EL
Sonova Holding AG
William Demant Holding A/S
Nurotron Biotechnology Co. Ltd.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Active Implantable Device Market:

Abbott achieved a significant technological milestone in February 2022 with the launch of patient implants for its AVEIR DR i2i pivotal clinical study, featuring a dual-chamber leadless pacemaker system. This implantation marks a global first within the crucial trial, showcasing the advancement of leadless pacing technology.

Increased prevalence of cardiovascular disease, neurological disease, and ENT problems is fuelling the demand for active implant devices, propelling the market growth. The growing aging population, investments, and funds to develop technologically advanced products, expanded application of neurostimulators, and favorable reimbursement in several procedures like ENT in developed countries are some of the factors driving the revenue growth of this market. Additional factors expected to support market revenue growth in the future include

Increased investments in R&D activities.
Rising funding for the Active implantable device market.
A strong focus on creating technologically sound active implantable devices.

The use of innovative active implantable devices and launches of newly advanced products are expected to boost market growth. Furthermore, governments and organizations are also putting more emphasis on enhancing accessibility and support to the individuals and making them more aware of the disease and its consequences and the advancement of the treatment by organizing the camps and celebrating the days or weeks related to the concerned disease which is creating a lot of opportunities for active implantable device market. However, some significant constraints are anticipated to restrain overall market growth to a certain stretch over the projected period, including device failure and network security. In addition, the high cost and adverse compensation policies of implantable devices are hindering market growth.

Active Implantable Devices Market Segmentation:

By Product

Implantable Cardiac Pacemakers
Implantable Cardioverter Defibrillators
- Transvenous Implantable Cardioverter Defibrillators
  - Biventricular Implantable Cardioverter Defibrillators
  - Dual-Chamber Implantable Cardioverter Defibrillators
  - Single-Chamber Implantable Cardioverter Defibrillators
- Subcutaneous Implantable Cardioverter Defibrillators
Ventricular Assist Devices
Implantable Heart Monitors/Insertable Loop Recorders
Implantable Hearing Devices
Neurostimulators
- Spinal Cord Stimulators
- Deep Brain Stimulators
- Sacral Nerve Stimulators
- Vagus Nerve Stimulators
- Gastric Electrical Stimulators

By Region

North America
Europe
Asia-Pacific
Latin America
Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. The North America region is anticipated to lead the market owing to the rising ageing population, increase in the occurrence of appalling diseases, rise in the overall healthcare expenditure and initiation of multiple projects for improving the healthcare infrastructure. The Asia Pacific region, however, is anticipated to grow at a remarkable rate during the forecasted timeframe owing to the rising geriatric population and increased preference towards fast and oily foods leading to obesity. Additionally, increased financial assistance from public and private entities for developing an efficient healthcare infrastructure has propelled the market growth in the region.

Competitive Landscape:

Tier 1 players- established companies in the market with a major market share
Tier 2 players
Emerging players which are growing rapidly
New Entrants

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key market trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the Global Active Implantable Devices Market By Product and By Region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization Mobility Care offered are free of charge with purchase of any license of the report
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

1. Market Introduction
- 1. Objectives of the Study
  2. Market Definition
  3. Market Scope
  3.1. Years Considered for the Study
  3.2. Market Covered
  4. Currency
  5. Limitations
  6. Stakeholders
2. Research Methodology
- 1. Research Data
  1.1. Secondary Data
  1.1.1. Key Data from Secondary Sources
  1.2. Primary Data
  1.2.1. Key Data from Primary Sources
  2. Market Size Estimation
  3. Market Breakdown and Data Triangulation
  4. Assumptions for the Study
3. Executive Summary
- 1. Market Outlook
  2. Segment Outlook
  3. Competitive Insights
4. Active Implantable Devices Market Variables, Trends and Scope
- 1. Market Lineage Outlook
  2. Penetration and Growth Prospect Mapping
  3. Industry Value Chain Analysis
  4. Cost Analysis Breakdown
  5. Technology Overview
  6. Regulatory Framework
  6.1. Reimbursement Framework
  6.2. Standards and Compliances
5. Market Overview
- 1. Market Dynamics
  1.1. Market Driver Analysis
  1.1.1. Increasing focus of Active Implantable Devices Companies on Brand Protection
  1.1.2. Untapped Opportunities in Emerging Regions
  1.2. Market Restraint Analysis
  1.2.1. High Cost Associated with Implementation of Predictive Analysis
  1.3. Industry Challenges
  1.3.1. Presence of Ambiguous Regulatory Framework
6. Active Implantable Devices Market Analysis Tools
- 1. Industry Analysis - Porter’s
  1.1. Supplier Power
  1.2. Buyer Power
  1.3. Substitution Threat
  1.4. Threat from New Entrants
  1.5. Competitive Rivalry
  2. Pestel Analysis
  2.1. Political Landscape
  2.2. Environmental Landscape
  2.3. Social Landscape
  2.4. Technology Landscape
  2.5. Legal Landscape
  3. Major Deals And Strategic Alliances Analysis
  3.1. Joint Ventures
  3.2. Mergers and Acquisitions
  3.3. Licensing and Partnership
  3.4. Technology Collaborations
  3.5. Strategic Divestments
  4. Market Entry Strategies
  5. Case Studies
7. Active Implantable Devices Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
- 1. Implantable Cardiac Pacemakers
  2. Implantable Cardioverter Defibrillators
  2.1. Transvenous Implantable Cardioverter Defibrillators
  2.1.1. Biventricular Implantable Cardioverter Defibrillators
  2.1.2. Dual-Chamber Implantable Cardioverter Defibrillators
  2.1.3. Single-Chamber Implantable Cardioverter Defibrillators
  2.2. Subcutaneous Implantable Cardioverter Defibrillators
  3. Ventricular Assist Devices
  4. Implantable Heart Monitors/Insertable Loop Recorders
  5. Implantable Hearing Devices
  6. Neurostimulators
  6.1. Spinal Cord Stimulators
  6.2. Deep Brain Stimulators
  6.3. Sacral Nerve Stimulators
  6.4. Vagus Nerve Stimulators
  6.5. Gastric Electrical Stimulators
8. North America Active Implantable Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. U.S.A
  2.2. Canada
  2.3. Mexico
  3. Market Size (USD Million) Forecast for North America 2023-2031
9. Latin America Active Implantable Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Brazil
  2.2. Venezuela
  2.3. Argentina
  2.4. Rest of Latin America
  3. Market Size (USD Million) Forecast for Latin America 2023-2031
10. Europe Active Implantable Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Germany
  2.2. U.K
  2.3. France
  2.4. Italy
  2.5. Spain
  2.6. Russia
  2.7. Poland
  2.8. Rest of Europe
  3. Market Size (USD Million) Forecast for Europe 2023-2031
11. Asia Pacific Active Implantable Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Japan
  2.2. China
  2.3. India
  2.4. Australia and New Zealand
  2.5. ASEAN
  2.6. Rest of Asia Pacific
  3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031
12. Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. GCC
  2.2. Israel
  2.3. South Africa
  2.4. Rest of MEA
  3. Market Size (USD Million) Forecast for MEA 2023-2031
13. Market Share Analysis and Competitive Landscape
- 1. Global Landscape - Key Players, Revenue and Presence
  2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
  3. Global Emerging Companies
  4. North America - Market Share Analysis and Key Regional Players
  5. Europe - Market Share Analysis and Key Regional Players
  6. Asia Pacific - Market Share Analysis and Key Regional Players
  7. Global Key Player - Growth Matrix
14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
- 1. Medtronic plc
  1.1. Company Overview
  1.2. Product Portfolio
  1.3. SWOT Analysis
  1.4. Financial Overview
  1.5. Strategic Overview
  2. Abbott Laboratories
  2.1. Company Overview
  2.2. Product Portfolio
  2.3. SWOT Analysis
  2.4. Financial Overview
  2.5. Strategic Overview
  3. Boston Scientific Corporation
  3.1. Company Overview
  3.2. Product Portfolio
  3.3. SWOT Analysis
  3.4. Financial Overview
  3.5. Strategic Overview
  4. BIOTRONIK SECo. KG
  4.1. Company Overview
  4.2. Product Portfolio
  4.3. SWOT Analysis
  4.4. Financial Overview
  4.5. Strategic Overview
  5. LivaNova PLC
  5.1. Company Overview
  5.2. Product Portfolio
  5.3. SWOT Analysis
  5.4. Financial Overview
  5.5. Strategic Overview
  6. Cochlear Limited
  6.1. Company Overview
  6.2. Product Portfolio
  6.3. SWOT Analysis
  6.4. Financial Overview
  6.5. Strategic Overview
  7. MED-EL
  7.1. Company Overview
  7.2. Product Portfolio
  7.3. SWOT Analysis
  7.4. Financial Overview
  7.5. Strategic Overview
  8. Sonova Holding AG
  8.1. Company Overview
  8.2. Product Portfolio
  8.3. SWOT Analysis
  8.4. Financial Overview
  8.5. Strategic Overview
  9. William Demant Holding A/S
  9.1. Company Overview
  9.2. Product Portfolio
  9.3. SWOT Analysis
  9.4. Financial Overview
  9.5. Strategic Overview
  10. Nurotron Biotechnology Co. Ltd.
  10.1. Company Overview
  10.2. Product Portfolio
  10.3. SWOT Analysis
  10.4. Financial Overview
  10.5. Strategic Overview
15. Pre and Post COVID-19 Impact
- 1. Positive influence on the healthcare industry
  2. The financial disruption of the manufacturing sector
  3. Impact of COVID-19 on emerging companies
  4. Significant mandates in the healthcare regulations initiated by administrations
  5. The overall economic slowdown of the developing and developed nations
16. FutureWise SME Key Takeaway Points for Client

Data Pack license: Data Pack license: $1250

Single user license: Single user license: $2850

Multi user license: Multi user license: $3850

Corporate license: Corporate license: $5000

Ask for Discount

Buy Now

Customize This Report

Partner

Report Overview

Table of Contents

List of Tables

List of figures

Overview

Table of Contents

Report Overview

Table of Contents

List of Tables

List of figures

Need Assistance

What you get

What's included

Our Clients